WADE MARION: Open Payments
NPI 1609821289 · ELKIN, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$835 in 26 payments from 14 companies in 2025. Trend: 2023 $32 · 2024 $167 · 2025 $835
Food & beverage: $835
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $201 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $151 |
| CeQur Corporation | 1 | $99 |
| Paratek Pharmaceuticals, Inc. | 2 | $99 |
| Otsuka America Pharmaceutical, Inc. | 3 | $67 |
| AstraZeneca Pharmaceuticals LP | 2 | $44 |
| Viatris Specialty LLC | 2 | $37 |
| Lundbeck LLC | 1 | $28 |
| GlaxoSmithKline, LLC. | 1 | $22 |
| Axsome Therapeutics, Inc. | 1 | $20 |
Products named: Wegovy, CAPLYTA, CeQur Simplicity, NUZYRA, REXULTI, YUPELRI, BREZTRI, Ozempic.
Industry payments across NC — which companies pay providers there.
